Search

Your search keyword '"Pellicelli A"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Pellicelli A" Remove constraint Author: "Pellicelli A" Publisher elsevier bv Remove constraint Publisher: elsevier bv
221 results on '"Pellicelli A"'

Search Results

1. WED-391 Long-term virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with bulevirtide monotherapy for up to 120 weeks: a retrospective multicenter european study (save-d)

2. WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)

3. OS-120 Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis

5. Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

6. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

7. Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication

8. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

9. PB0802 Platelet Features that Identify Early Stages of Liver Disease Progression

10. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients

11. Role of gut-derived endotoxins in porto-sinusoidal vascular disease

12. Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli

13. Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study

15. Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)

16. Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy: the retrospective multicenter European study (Save-D)

17. AFP score and metroticket 2.0 perform similarly and could be used in a 'within-ALL' clinical decision tool

18. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

19. HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli

20. Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di)

21. Efficacy of lenvatinib in intermediate stage and advanced hepatocellular carcinoma: Results of monotherapy and combination with locoregional treatment

22. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

23. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

24. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

25. Somebody is hiding something: Disentangling interpersonal level drivers and consequences of knowledge hiding in international entrepreneurial firms

27. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

28. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

29. HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli

31. Over the mask of innovation management in the world of Big Data

33. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

34. Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid

38. Predictors of Serious Adverse Event and Non-response in Cirrhotic Patients With Primary Biliary Cholangitis under Obeticholic Acid

39. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

41. Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C

42. Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation

46. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

48. Lrp6 is a target of the PTH-activated αNAC transcriptional coregulator

Catalog

Books, media, physical & digital resources